Douglas Keehn, DO
Pain Medicine · Fort Atkinson, WINPI 1942277751
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $9,205 of the $11,848 with a category attached, or 77.7%. Boston Scientific accounts for 88.0% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2021 at $9,223 and has fallen 84.3% since, to $1,452 in 2025.
Across 30 payments — averaging $394.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$10K
- Curonix LLC$750
- Johnson & Johnson$313
- Spinal Simplicity, LLC$168
- Nevro Corp.$77
- Globus Medical$63
- plus $48 from 2 others
Across 24 payments — averaging $2074.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$50K
What the payments were for
- Consulting fees$9,20578%
- Travel & lodging$7506%
- Food & beverage$1,89316%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 20 | $10,429 |
| Curonix LLC | 2 | $750 |
| Johnson & Johnson | 2 | $313 |
| Spinal Simplicity, LLC | 2 | $168 |
| Nevro Corp. | 1 | $77 |
| Globus Medical | 1 | $63 |
| Abbott | 1 | $35 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,848 in reported general payments places this provider in the 80th percentile of 82 pain medicine providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 33 | $409 |
| Gabapentin | 28 | $389 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 16 | $338 |
| Celecoxib | 17 | $319 |
| Pregabalin | 15 | $289 |
| Baclofen | 13 | $250 |
| Duloxetine Hcl | 12 | $120 |
| Tizanidine Hcl | 11 | $118 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Fort Atkinson
- Alaa Abd-ElsayedMadison$1.3M
- Michael JungWest Bend$339K
- Frederick FreitagMadison$157K
- Atit ShahSheboygan$76K
- Thomas FaullMadison$66K
- Ammar MahmoudNeenah$57K
- Jeremy ScarlettSheboygan$40K
- Thomas StaussGreenfield$34K
- Matthew FischerAppleton$21K
- Jeffrey QuintanaMilwaukee$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.